FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

22223811000001102: Triclabendazole 250mg tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
73325101000001119 Triclabendazole 250mg tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
73325201000001114 Triclabendazole 250mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Triclabendazole 250mg tablets Has active ingredient Triclabendazole false Inferred relationship Existential restriction modifier
Triclabendazole 250mg tablets Is a Triclabendazole true Inferred relationship Existential restriction modifier
Triclabendazole 250mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Triclabendazole 250mg tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Triclabendazole 250mg tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Triclabendazole 250mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Triclabendazole 250mg tablets Plays role Anthelmintic therapeutic role true Inferred relationship Existential restriction modifier
Triclabendazole 250mg tablets Is a Triclabendazole false Inferred relationship Existential restriction modifier
Triclabendazole 250mg tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Triclabendazole 250mg tablets Has specific active ingredient Triclabendazole false Inferred relationship Existential restriction modifier
Triclabendazole 250mg tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Triclabendazole 250mg tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Triclabendazole 250mg tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Triclabendazole 250mg tablets Has active ingredient Benzimidazole with anthelmintic mechanism of action false Inferred relationship Existential restriction modifier
Triclabendazole 250mg tablets Has specific active ingredient Triclabendazole true Inferred relationship Existential restriction modifier
Triclabendazole 250mg tablets Is a Product containing triclabendazole false Inferred relationship Existential restriction modifier
Triclabendazole 250mg tablets Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Egaten 250mg tablets (Imported (Switzerland)) Is a True Triclabendazole 250mg tablets Inferred relationship Existential restriction modifier
Triclabendazole 250mg tablets 4 tablet Has VMP True Triclabendazole 250mg tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start